XRCC5 Anticorps
(X-Ray Repair Complementing Defective Repair in Chinese Hamster Cells 5 (Double-Strand-Break Rejoining) (XRCC5))
Choisissez l’un des 134 anticorps XRCC5 de notre liste de produits basés sur 10 publications et 107 images de validation.
Découvrez des anticorps XRCC5 fiables issus d’une large sélection de fabricants renommés. Notre portefeuille permet une détection précise de XRCC5 dans plusieurs espèces, y compris Human, Mouse, Monkey, Rat, Dog, Hamster, Horse, Bat, Cow, Guinea Pig, Pig, Rabbit, et prend en charge diverses applications de recherche telles que WB, IHC, IF, ELISA, IHC (p).
Trouvez rapidement l’anticorps adapté grâce à nos outils de recherche, de filtrage et de comparaison. Chaque page produit fournit des données de validation détaillées, des références bibliographiques et des retours d’utilisateurs. Contrairement aux ressources dédiées uniquement à la comparaison, vous pouvez acheter directement les anticorps sur notre site. Choisissez parmi des anticorps polyclonaux, monoclonaux ou recombinants XRCC5, issus de différents hôtes tels que Rabbit, Mouse, Goat. Parcourez nos produits ci-dessous et commandez directement pour soutenir vos recherches en toute confiance.
Les noms alternatifs de XRCC5 sont XRCC5, Xrcc5, xrcc5.L.
Filtrer les résultats:
134 Résultats
XRCC5
Reactivité: Humain, Singe
WB, IHC, IF, IHC (p), ICC
Hôte: Lapin
Polyclonal
unconjugated
XRCC5
Reactivité: Humain
WB, IHC, IP, IHC (p), ICC
Hôte: Lapin
Polyclonal
unconjugated
XRCC5
Reactivité: Humain
WB, IHC, IF, IHC (p)
Hôte: Lapin
Polyclonal
unconjugated
XRCC5
Reactivité: Souris
IHC
Hôte: Lapin
Monoclonal
A283
unconjugated
Recombinant Antibody
XRCC5
Reactivité: Humain, Souris
WB, IHC, IHC (p)
Hôte: Lapin
Polyclonal
unconjugated
XRCC5
Reactivité: Humain, Singe
WB, IHC, ELISA, IF
Hôte: Lapin
Polyclonal
unconjugated
XRCC5
Reactivité: Humain
WB, IHC, ELISA, IF
Hôte: Lapin
Polyclonal
unconjugated
XRCC5
Reactivité: Humain
WB, IHC, ELISA, IF
Hôte: Lapin
Polyclonal
unconjugated
XRCC5
Reactivité: Humain
WB, IHC
Hôte: Souris
Monoclonal
XRCC5-7317
unconjugated
XRCC5
Reactivité: Humain
WB, IHC
Hôte: Souris
Monoclonal
XRCC5-7318
unconjugated
XRCC5
Reactivité: Humain
WB, IHC
Hôte: Souris
Monoclonal
XRCC5-7314
unconjugated
XRCC5
Reactivité: Humain
IHC
Hôte: Souris
Monoclonal
XRCC5-7313
unconjugated
XRCC5
Reactivité: Humain
WB, IHC
Hôte: Souris
Monoclonal
XRCC5-7316
unconjugated
XRCC5
Reactivité: Humain
WB, IHC
Hôte: Souris
Monoclonal
XRCC5-7316
unconjugated
XRCC5
Reactivité: Humain
WB, IHC
Hôte: Souris
Monoclonal
XRCC5-7314
unconjugated
XRCC5
Reactivité: Humain
IHC
Hôte: Lapin
Monoclonal
XRCC5-8703R
unconjugated
Recombinant Antibody
XRCC5
Reactivité: Humain
IHC
Hôte: Lapin
Monoclonal
XRCC5-8703R
unconjugated
Recombinant Antibody
XRCC5
Reactivité: Humain
IHC
Hôte: Souris
Monoclonal
XRCC5-7313
unconjugated
XRCC5
Reactivité: Humain
WB, IHC, IF, IP, IHC (p), PLA
Hôte: Lapin
Polyclonal
unconjugated
Dernières publications pour nos XRCC5 Anticorps
: "Downregulation of TMPRSS4 Enhances Triple-Negative Breast Cancer Cell Radiosensitivity Through Cell Cycle and Cell Apoptosis Process Impairment." dans: Asian Pacific journal of cancer prevention : APJCP, Vol. 20, Issue 12, pp. 3679-3687, (2020) (PubMed).
: "Histone H3K27 methylation modulates the dynamics of FANCD2 on chromatin to facilitate NHEJ and genome stability." dans: Journal of cell science, Vol. 131, Issue 12, (2018) (PubMed).
: "BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapy." dans: Cancer letters, Vol. 423, pp. 60-70, (2018) (PubMed).
: "Impaired DNA double-strand break repair contributes to the age-associated rise of genomic instability in humans." dans: Cell death and differentiation, Vol. 23, Issue 11, pp. 1765-1777, (2017) (PubMed).
: "Influence of XRCC4 expression in esophageal cancer cells on the response to radiotherapy." dans: Medical molecular morphology, Vol. 50, Issue 1, pp. 25-33, (2016) (PubMed).
: "Expression of Ku70 predicts results of radiotherapy in prostate cancer." dans: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], Vol. 193, Issue 1, pp. 29-37, (2016) (PubMed).
: "Serum anti-Ku86 is a potential biomarker for early detection of hepatitis C virus-related hepatocellular carcinoma." dans: Biochemical and biophysical research communications, Vol. 421, Issue 4, pp. 837-43, (2012) (PubMed).
: "Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines." dans: Breast cancer research : BCR, Vol. 11, Issue 6, pp. R83, (2010) (PubMed).
: "The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A." dans: BMC medicine, Vol. 8, pp. 19, (2010) (PubMed).
: "Androgen modulation of coregulator expression in prostate cancer cells." dans: Molecular endocrinology (Baltimore, Md.), Vol. 23, Issue 4, pp. 572-83, (2009) (PubMed).
: "Histone H3K27 methylation modulates the dynamics of FANCD2 on chromatin to facilitate NHEJ and genome stability." dans: Journal of cell science, Vol. 131, Issue 12, (2018) (PubMed).
: "BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapy." dans: Cancer letters, Vol. 423, pp. 60-70, (2018) (PubMed).
: "Impaired DNA double-strand break repair contributes to the age-associated rise of genomic instability in humans." dans: Cell death and differentiation, Vol. 23, Issue 11, pp. 1765-1777, (2017) (PubMed).
: "Influence of XRCC4 expression in esophageal cancer cells on the response to radiotherapy." dans: Medical molecular morphology, Vol. 50, Issue 1, pp. 25-33, (2016) (PubMed).
: "Expression of Ku70 predicts results of radiotherapy in prostate cancer." dans: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], Vol. 193, Issue 1, pp. 29-37, (2016) (PubMed).
: "Serum anti-Ku86 is a potential biomarker for early detection of hepatitis C virus-related hepatocellular carcinoma." dans: Biochemical and biophysical research communications, Vol. 421, Issue 4, pp. 837-43, (2012) (PubMed).
: "Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines." dans: Breast cancer research : BCR, Vol. 11, Issue 6, pp. R83, (2010) (PubMed).
: "The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A." dans: BMC medicine, Vol. 8, pp. 19, (2010) (PubMed).
: "Androgen modulation of coregulator expression in prostate cancer cells." dans: Molecular endocrinology (Baltimore, Md.), Vol. 23, Issue 4, pp. 572-83, (2009) (PubMed).
Pseudonymes pour XRCC5 Anticorps
X-ray repair cross complementing 5 (XRCC5) AnticorpsX-ray repair complementing defective repair in Chinese hamster cells 5 (Xrcc5) Anticorps
X-ray repair cross complementing 5 (Xrcc5) Anticorps
X-ray repair complementing defective repair in Chinese hamster cells 5 L homeolog (xrcc5.L) Anticorps
AI314015 Anticorps
KARP-1 Anticorps
KARP1 Anticorps
Ku80 Anticorps
KU80 Anticorps
Ku86 Anticorps
KUB2 Anticorps
Kup80 Anticorps
NFIV Anticorps
XRCC5 Anticorps
xrcc5-a Anticorps
Avez-vous cherché autre chose?
- XRCC4 Anticorps
- XRCC3 Anticorps
- XRCC2 Anticorps
- XRCC1 Anticorps
- xpr1 Anticorps
- XPOT Anticorps
- XPO5 Anticorps
- XPO4 Anticorps
- XPO1 Anticorps
- XPNPEP3 Anticorps
- XPNPEP2 Anticorps
- XPNPEP1 Anticorps
- XPC Anticorps
- XPA Anticorps
- XKRX Anticorps
- XKR7 Anticorps
- XKR3 Anticorps
- XIRP2 Anticorps
- XIRP1 Anticorps
- XIAP Anticorps
- XRCC6 Anticorps
- XRCC6BP1 Anticorps
- XRN1 Anticorps
- XRN2 Anticorps
- XRRA1 Anticorps
- XXYLT1 Anticorps
- XYLB Anticorps
- XYLT1 Anticorps
- XYLT2 Anticorps
- Y Box Binding Protein 2 Anticorps
- YAF2 Anticorps
- YAP1 Anticorps
- YARS Anticorps
- YARS2 Anticorps
- ybeY Anticorps
- YBX1 Anticorps
- YEATS2 Anticorps
- YES1 Anticorps
- YIF1A Anticorps
- Yip1 Interacting Factor Homolog B Anticorps
Vous êtes ici:
